KERATINOCYTE GROWTH-FACTOR CAUSES PROLIFERATION OF UROTHELIUM IN-VIVO

被引:70
作者
YI, ES
SHABAIK, AS
LACEY, DL
BEDOYA, AA
YIN, SM
HOUSLEY, RM
DANILENKO, DM
BENSON, W
COHEN, AM
PIERCE, GF
THOMASON, A
ULICH, TR
机构
[1] AMGEN INC,AMGEN CTR,DIV BIOL,THOUSAND OAKS,CA 91320
[2] UNIV CALIF SAN DIEGO,SCH MED,DEPT PATHOL,SAN DIEGO,CA
关键词
GROWTH SUBSTANCES;
D O I
10.1016/S0022-5347(01)66930-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To determine the effect of keratinocyte growth factor (KGF), a mesenchymally derived epithelial growth factor that can cause proliferation of pulmonary, gastrointestinal and mammary epithelia, on urothelium. Materials and Methods: Recombinant human KGF was systemically administered to rats and Rhesus monkeys, and the proliferative effects on the bladder were evaluated. Results: Keratinocyte growth factor causes proliferation of transitional epithelial cells. Proliferating cell nuclear antigen (PCNA) expression in rat bladder is dramatically increased along the basal layer of urothelium 1, 3, 7 and 14 days after daily injections of KGF. Incorporation of 5-bromodeoxyuridine (BrdU) at 7 and 14 days in the urothelium of KGF-treated rats parallels PCNA immunoreactivity and confirms that KGF increases DNA synthesis in urothelial cells. Urothelial cell proliferation is accompanied histologically by an increase in mitotic activity. Keratinocyte growth factor-induced PCNA expression is reversible upon cessation of KGF administration. Keratinocyte growth factor mRNA and receptor mRNA are detected by whole organ RNAse protection assays of the urinary bladder and the kidney of normal rats. Rhesus monkeys receiving KGF for 7 days demonstrate a dramatic incorporation of BrdU in the urothelium of the bladder and renal pelvis as well as in the collecting ducts of the kidney. Conclusion: Systemic administration of KGF causes rapid and striking proliferation of urothelium.
引用
收藏
页码:1566 / 1570
页数:5
相关论文
共 26 条
[1]   MODULATION OF INVITRO-CELL GROWTH OF HUMAN AND MURINE UROTHELIAL TUMOR-CELL LINES UNDER THE INFLUENCE OF INTERLEUKIN-3, GRANULOCYTE-COLONY-STIMULATING, MACROPHAGE-COLONY-STIMULATING AND GRANULOCYTE-COLONY-STIMULATING FACTOR [J].
BLOCK, T ;
SCHMID, F ;
GEFFKEN, B ;
TREIBER, U ;
BUSCH, R ;
HARTUNG, R .
UROLOGICAL RESEARCH, 1992, 20 (04) :289-292
[2]   INHIBITORY EFFECTS ON INVITRO-CELL GROWTH OF HUMAN UROTHELIAL TUMOR-CELL LINES UNDER THE COMBINED ADMINISTRATION OF HEMATOPOIETIC GROWTH-FACTORS AND CLINICALLY RELEVANT ANTINEOPLASTIC AGENTS [J].
BLOCK, T ;
TREIBER, U ;
GEFFKEN, B ;
VOGEL, M ;
HANAUSKE, AR ;
SCHMID, F ;
HARTUNG, R ;
BUSCH, R .
UROLOGICAL RESEARCH, 1993, 21 (03) :217-221
[3]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[4]   REDUCED EXPRESSION OF TGF-BETA IS ASSOCIATED WITH ADVANCED DISEASE IN TRANSITIONAL CELL-CARCINOMA [J].
COOMBS, LM ;
PIGOTT, DA ;
EYDMANN, ME ;
PROCTOR, AJ ;
KNOWLES, MA .
BRITISH JOURNAL OF CANCER, 1993, 67 (03) :578-584
[5]   THE IMPACT OF IATROGENIC UROTHELIAL TRAUMA ON URINARY LEVELS OF TRANSFORMING GROWTH FACTOR-ALPHA [J].
COOPER, CS ;
SEE, WA .
JOURNAL OF UROLOGY, 1992, 147 (06) :1647-1649
[6]   HUMAN KGF IS FGF-RELATED WITH PROPERTIES OF A PARACRINE EFFECTOR OF EPITHELIAL-CELL GROWTH [J].
FINCH, PW ;
RUBIN, JS ;
MIKI, T ;
RON, D ;
AARONSON, SA .
SCIENCE, 1989, 245 (4919) :752-755
[7]   EPIDERMAL GROWTH-FACTOR IN URINE FROM THE PATIENTS WITH UROTHELIAL TUMORS [J].
FUSE, H ;
MIZUNO, I ;
SAKAMOTO, M ;
KATAYAMA, T .
UROLOGIA INTERNATIONALIS, 1992, 48 (03) :261-264
[8]  
GRATZNER HG, 1980, SCIENCE, V218, P474
[9]  
GUTHIER J, 1990, CANCER RES, V50, P293
[10]  
HAINAU B, 1974, CANCER-AM CANCER SOC, V33, P115, DOI 10.1002/1097-0142(197401)33:1<115::AID-CNCR2820330118>3.0.CO